Association between CYP2C19 genotype and the additional effect of cilostazol to clopidogrel resistance in neuroendovascular therapy.
Tajima H, Izumi T, Miyachi S, Matsubara N, Ito M, Imai T, Nishihori M, Shintai K, Okamoto S, Araki Y, Kumakura Y, Furukawa-Hibi Y, Yamada K, Wakabayashi T.
Tajima H, et al. Among authors: nishihori m.
Nagoya J Med Sci. 2018 May;80(2):207-215. doi: 10.18999/nagjms.80.2.207.
Nagoya J Med Sci. 2018.
PMID: 29915438
Free PMC article.